MetaCap

abrdn Life Sciences Investors (HQL) vs Oxford Lane Capital (OXLC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

abrdn Life Sciences Investors (HQL) has outperformed Oxford Lane Capital (OXLC) over the past year, losing 8.5% versus a loss of 62.5%. Over five years, HQL leads with a -22.8% price change compared with -87.4% for OXLC. Oxford Lane Capital offers the higher dividend yield (48.58% vs 12.42%).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

HQL-8.51%OXLC-62.46%
+40%-14%-68%
Nov 21, 20251 yearNov 20, 2026
HQL-24.98%OXLC-87.41%
+14%-39%-92%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

HQL versus OXLC key metrics
MetricHQLOXLC
Share price$15.38$4.94
Market cap—$484.27M
1-day change-3.81%0.00%
YTD return-8.34%-66.26%
1-year return-8.51%-62.46%
5-year return-22.83%-87.37%
P/E ratio (TTM)2.32—
Forward P/E—1.41
EPS (TTM)$6.64$-5.62
Dividend yield12.42%48.58%
Annual dividend$1.91$2.40
52-week high$22.67$15.39
52-week low$15.35$4.62
Distance from 52-week high-32.16%-67.90%
Analyst consensus—none
Avg. price target upside—+153.04%
Average volume129.21K1.54M
Shares outstanding—98.03M
SectorFinanceFinance
IndustryInvestment ManagersInvestment Managers

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • HQL has outperformed OXLC by 54.0 percentage points over the past year.
  • Oxford Lane Capital offers a meaningfully higher dividend yield (48.58% vs 12.42%).

About abrdn Life Sciences Investors

HQL stock →

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.

Finance · Investment Managers

About Oxford Lane Capital

OXLC stock →

Oxford Lane Capital Corp. is a close ended fund launched and managed by Oxford Lane Management LLC.

Finance · Investment Managers

HQL vs OXLC FAQ

Which stock has performed better over the past year, HQL or OXLC?

HQL returned -8.51% over the past 12 months, compared with -62.46% for OXLC (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, abrdn Life Sciences Investors or Oxford Lane Capital?

Oxford Lane Capital has the higher yield at 48.58%, compared with 12.42% for abrdn Life Sciences Investors.

Are abrdn Life Sciences Investors and Oxford Lane Capital in the same industry?

Yes. Both are classified in the Investment Managers industry within the Finance sector.

More comparisons